[Omission factors in detecting early stage prostate cancer by TRUS needle biopsy].
Zhonghua Nan Ke Xue
; 11(6): 431-2, 437, 2005 Jun.
Article
em Zh
| MEDLINE
| ID: mdl-15999487
ABSTRACT
OBJECTIVE:
To analyze and reduce the omission factors in detecting early stage prostate cancer by TRUS needle biopsy, and to improve the diagnosis of the disease.METHODS:
A total of 80 benign prostatic hyperplasia patients suspected of prostatic carcinoma underwent TRUS sextant biopsies. The pathological results being negative, the patients received transurethral resection of the prostate (TURP).RESULTS:
After TURP, 25 cases were pathologically diagnosed as prostate cancer, with an omission rate of 31.25% (25/80). Of the diagnosed cancer patients, 10 were treated by radical perineum prostatectomy, 8 by surgical castration, and 7 by medical castration.CONCLUSION:
Some tumors may fail to be detected by TRUS needle biopsy. Serial or multi-core needle biopsies can decrease the omission rate in the diagnosis of organ confined cancer.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Próstata
/
Neoplasias da Próstata
Idioma:
Zh
Ano de publicação:
2005
Tipo de documento:
Article